Adith Mohan

UNSW Sydney — Australia

Neuroscience · Life Sciences

15h-index1.2kcitations57works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Transcranial Magnetic Stimulation Studies(8), Obsessive-Compulsive Spectrum Disorders(8), Neurological disorders and treatments(7), Mental Health and Psychiatry(7), Schizophrenia research and treatment(5)

Publications56 total

Identification of circular RNAs associated with ageing of the dorsolateral prefrontal cortex across the adult lifespan
Neurobiology of Aging·2025Open Access
CS10 From presentation to diagnosis: clinical characterisation of first episode psychosis and autoimmune encephalitis in a tertiary centre
2025Open Access
How academics can lead with empathy
Nature India·2025
Altered self-processing brain networks in paediatric functional neurological disorder
NeuroImage Clinical·2025· 3 citedOpen Access
Identification of Circular RNAs associated with Ageing of the Dorsolateral Prefrontal Cortex across the Adult Lifespan
2024Open Access
Case report: Down syndrome regression disorder, catatonia, and psychiatric and immunomodulatory interventions
Frontiers in Psychiatry·2024· 1 citedOpen Access
Functional neurological disorder clinics in Australasia: A binational survey
Journal of Clinical Neuroscience·2024· 1 citedOpen Access
Evaluation of a community‐based brief intervention service for youth in crisis with suicidal ideation or self‐harm
Early Intervention in Psychiatry·2024· 3 citedOpen Access
Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial
Brain Behavior and Immunity·2023· 29 citedOpen Access
Principles for delivering improved care of people with functional seizures: Closing the treatment gap
Australian & New Zealand Journal of Psychiatry·2023· 11 cited
Tetrahydrocannabinol and Cannabidiol in Tourette Syndrome
NEJM Evidence·2023· 25 citedOpen Access
Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing
Frontiers in Pharmacology·2023· 20 citedOpen Access
Neurocognitive Disorders
2023· 2 cited
Anti-<i>N</i>-Methyl-<scp>d</scp>-Aspartate Receptor Antibody Testing in First-Episode Psychosis: Universal or Targeted Testing
Journal of Neuropsychiatry·2022· 1 cited
Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: Opportunities and challenges
Australian & New Zealand Journal of Psychiatry·2022
Functional neurological disorders: an Australian interdisciplinary perspective
The Medical Journal of Australia·2022· 13 citedOpen Access
Development and clinimetric testing of the Unified Drug-Induced Movement Disorders Scale (UDIMS)
2022Open Access
Financial strain moderates genetic influences on self-rated health: support for diathesis–stress model of gene–environment interplay
Biodemography and Social Biology·2022· 4 citedOpen Access
Deep brain stimulation for treatment-refractory obsessive-compulsive disorder should be an accepted therapy in Australia
Australian & New Zealand Journal of Psychiatry·2021· 8 cited
A randomised, double-blind, sham-controlled trial of deep brain stimulation of the bed nucleus of the stria terminalis for treatment-resistant obsessive-compulsive disorder
Translational Psychiatry·2021· 101 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Perminder S. Sachdev(31), Cynthia Shannon Weickert(10), Colleen Loo(7), Angelo Alonzo(7), Donel Martin(7), Anbupalam Thalamuthu(7), Karen A. Mather(7), Mustafa M. Husain(4), William M. McDonald(4), John P. O’Reardon(4), Shawn M. McClintock(4), Sarah H. Lisanby(4), Philip Mosley(4), Julia Lappin(4), Vibeke S. Catts(4), Rodney Marsh(3), Peter A. Silburn(3), Lauren Taylor(3), Henry Brodaty(3), Thomas W. Weickert(3)